Loading articles...
Oncologist Reflects on Football's Lessons for Clinical Practice
A clinical oncologist discusses how principles from football, such as teamwork and strategic planning, inform their approach to patient care.
Mesothelioma Survival Challenges Persist in the US
Despite advances in oncology, mesothelioma survival rates in the US remain low, highlighting persistent challenges in early diagnosis and effective treatment.
CAR-T Masterstroke Or Biological Chaos?
In 2012, a 6-year-old with relapsed ALL became the first child successfully treated with CAR-T cell therapy. That case launched a revolution. Sarah Mitchell and James Carter explain how chimeric antigen receptor T cells are engineered, why CD19 was the firs...
Doctor-Patient Communication Improves Treatment Acceptance in Cancer
Effective doctor-patient communication, focusing on patient self-blame, significantly increases treatment acceptance rates in cancer patients.
HYRNUO® (Sevabertinib) Shows Efficacy in Advanced Solid Tumours
Sevabertinib, a novel tyrosine kinase inhibitor, demonstrates efficacy in advanced solid tumours, offering a new therapeutic option.
Oncodetect® MRD Test Shows Analytical Validity, Clinical Utility at ASCO
Molecular residual disease (MRD) detection is critical for oncology. The Oncodetect® test demonstrates analytical and clinical evidence.
TACE + Camrelizumab/Rivoceranib Improves OS in Unresectable HCC
A phase II trial demonstrates improved overall survival with TACE combined with camrelizumab and rivoceranib for unresectable HCC.
Subcutaneous Immunotherapy Offers Alternative Administration at ASCO 2026
A new subcutaneous immunotherapy formulation provides a convenient alternative for patients, potentially reducing administration time and healthcare resource utilization.
MCED Tests Show Promise for Earlier Cancer Detection at ASCO 2026
Multi-cancer early detection (MCED) tests offer a potential strategy for earlier cancer diagnosis, particularly for cancers lacking standard screening.